Efficacy and safety of colistin in the treatment of infections in the ICU caused by multidrug-resistant Gram-negative organisms

Benzer Materyaller

• Trends of resistance of Gram-negative bacteria in the ICU during a 3-year period
  Yazar:: Skiada, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Efficacy and safety of once daily dosing of colistin to critically ill patients
  Yazar:: Skiada, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• The use of recombinant factor VIIa as a haemostatic agent in ICU patients
  Yazar:: Vernikos, P, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
  Yazar:: Tsimogianni, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria
  Yazar:: Grion, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)